aeruginosin GE766
| Internal ID | 19c76073-551a-40d6-8c5c-35840cde902a |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Dipeptides |
| IUPAC Name | [(2S,3aS,6R,7aS)-1-[(2R,3S)-2-[[(2R)-3-(3-bromo-5-chloro-4-hydroxyphenyl)-2-hydroxypropanoyl]amino]-3-methylpentanoyl]-2-[4-(diaminomethylideneamino)butylcarbamoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-6-yl] hydrogen sulfate |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C29H44BrClN6O9S/c1-3-15(2)24(36-27(41)23(38)12-16-10-19(30)25(39)20(31)11-16)28(42)37-21-14-18(46-47(43,44)45)7-6-17(21)13-22(37)26(40)34-8-4-5-9-35-29(32)33/h10-11,15,17-18,21-24,38-39H,3-9,12-14H2,1-2H3,(H,34,40)(H,36,41)(H4,32,33,35)(H,43,44,45)/t15-,17-,18+,21-,22-,23+,24+/m0/s1 |
| InChI Key | WGFZRUTWFMYTPD-GPSFYHMWSA-N |
| Popularity | 3 references in papers |
| Molecular Formula | C29H44BrClN6O9S |
| Molecular Weight | 768.10 g/mol |
| Exact Mass | 766.17624 g/mol |
| Topological Polar Surface Area (TPSA) | 255.00 Ų |
| XlogP | 1.90 |
| Atomic LogP (AlogP) | 1.37 |
| H-Bond Acceptor | 9 |
| H-Bond Donor | 7 |
| Rotatable Bonds | 15 |
| DTXSID201186889 |
| RefChem:109933 |
| DTXCID001618206 |
| ((2S,3aS,6R,7aS)-1-((2R,3S)-2-(((2R)-3-(3-bromo-5-chloro-4-hydroxyphenyl)-2-hydroxypropanoyl)amino)-3-methylpentanoyl)-2-(4-(diaminomethylideneamino)butylcarbamoyl)-2,3,3a,4,5,6,7,7a-octahydroindol-6-yl) hydrogen sulfate |
| CHEMBL2207402 |
| CHEBI:199443 |
| (2S,3aS,6R,7aS)-1-[(2R,3S)-2-{[(2R)-3-(3-Bromo-5-chloro-4-hydroxyphenyl)-2-hydroxypropanoyl]amino}-3-methylpentanoyl]-2-[(4-carbamimidamidobutyl)carbamoyl]octahydro-1H-indol-6-yl hydrogen sulfate |
| [(2S,3aS,6R,7aS)-1-[(2R,3S)-2-[[(2R)-3-(3-bromo-5-chloro-4-hydroxyphenyl)-2-hydroxypropanoyl]amino]-3-methylpentanoyl]-2-[4-(diaminomethylideneamino)butylcarbamoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-6-yl] hydrogen sulate |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9327 | 93.27% |
| Caco-2 | - | 0.8633 | 86.33% |
| Blood Brain Barrier | - | 0.5250 | 52.50% |
| Human oral bioavailability | - | 0.7000 | 70.00% |
| Subcellular localzation | Mitochondria | 0.3865 | 38.65% |
| OATP2B1 inhibitior | - | 0.5712 | 57.12% |
| OATP1B1 inhibitior | + | 0.8068 | 80.68% |
| OATP1B3 inhibitior | + | 0.9366 | 93.66% |
| MATE1 inhibitior | - | 0.8000 | 80.00% |
| OCT2 inhibitior | + | 0.5250 | 52.50% |
| BSEP inhibitior | + | 0.8254 | 82.54% |
| P-glycoprotein inhibitior | + | 0.7104 | 71.04% |
| P-glycoprotein substrate | + | 0.8481 | 84.81% |
| CYP3A4 substrate | + | 0.7352 | 73.52% |
| CYP2C9 substrate | - | 0.6109 | 61.09% |
| CYP2D6 substrate | - | 0.7951 | 79.51% |
| CYP3A4 inhibition | + | 0.5134 | 51.34% |
| CYP2C9 inhibition | - | 0.6818 | 68.18% |
| CYP2C19 inhibition | - | 0.6265 | 62.65% |
| CYP2D6 inhibition | - | 0.8343 | 83.43% |
| CYP1A2 inhibition | - | 0.7161 | 71.61% |
| CYP2C8 inhibition | + | 0.6952 | 69.52% |
| CYP inhibitory promiscuity | - | 0.6891 | 68.91% |
| UGT catelyzed | + | 0.9000 | 90.00% |
| Carcinogenicity (binary) | + | 0.5065 | 50.65% |
| Carcinogenicity (trinary) | Non-required | 0.5668 | 56.68% |
| Eye corrosion | - | 0.9761 | 97.61% |
| Eye irritation | - | 0.9263 | 92.63% |
| Skin irritation | - | 0.7528 | 75.28% |
| Skin corrosion | - | 0.9086 | 90.86% |
| Ames mutagenesis | - | 0.5854 | 58.54% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.4480 | 44.80% |
| Micronuclear | + | 0.9200 | 92.00% |
| Hepatotoxicity | + | 0.5129 | 51.29% |
| skin sensitisation | - | 0.8239 | 82.39% |
| Respiratory toxicity | + | 0.7889 | 78.89% |
| Reproductive toxicity | + | 0.9000 | 90.00% |
| Mitochondrial toxicity | + | 0.6625 | 66.25% |
| Nephrotoxicity | - | 0.8860 | 88.60% |
| Acute Oral Toxicity (c) | III | 0.5713 | 57.13% |
| Estrogen receptor binding | + | 0.8339 | 83.39% |
| Androgen receptor binding | + | 0.7090 | 70.90% |
| Thyroid receptor binding | + | 0.5552 | 55.52% |
| Glucocorticoid receptor binding | + | 0.6645 | 66.45% |
| Aromatase binding | + | 0.6287 | 62.87% |
| PPAR gamma | + | 0.7160 | 71.60% |
| Honey bee toxicity | - | 0.7173 | 71.73% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.5500 | 55.00% |
| Fish aquatic toxicity | + | 0.9735 | 97.35% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.73% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.47% | 96.09% |
| CHEMBL4072 | P07858 | Cathepsin B | 99.29% | 93.67% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 98.69% | 83.82% |
| CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 98.57% | 95.34% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.11% | 94.45% |
| CHEMBL204 | P00734 | Thrombin | 97.99% | 96.01% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 97.86% | 85.31% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.23% | 91.11% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 96.89% | 95.52% |
| CHEMBL4506 | Q96EB6 | NAD-dependent deacetylase sirtuin 1 | 95.64% | 88.33% |
| CHEMBL261 | P00915 | Carbonic anhydrase I | 95.51% | 96.76% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 95.45% | 97.21% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 95.30% | 98.05% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 95.17% | 100.00% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 94.73% | 98.33% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.61% | 91.19% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 94.04% | 94.66% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 93.73% | 96.25% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.55% | 97.09% |
| CHEMBL3729 | P22748 | Carbonic anhydrase IV | 93.04% | 99.23% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 92.88% | 96.38% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 92.73% | 100.00% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 92.45% | 96.00% |
| CHEMBL238 | Q01959 | Dopamine transporter | 92.33% | 95.88% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.56% | 90.71% |
| CHEMBL3788 | O00444 | Serine/threonine-protein kinase PLK4 | 91.32% | 83.65% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 90.61% | 95.89% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 89.64% | 96.90% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 89.60% | 97.50% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 89.59% | 93.03% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 89.44% | 97.25% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 89.26% | 93.56% |
| CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 87.98% | 95.69% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 87.98% | 96.11% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 87.94% | 97.23% |
| CHEMBL5646 | Q6L5J4 | FML2_HUMAN | 87.86% | 100.00% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 87.41% | 95.56% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 87.20% | 100.00% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 87.01% | 98.59% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 86.70% | 96.67% |
| CHEMBL3025 | P23280 | Carbonic anhydrase VI | 86.17% | 97.50% |
| CHEMBL5905 | Q04828 | Aldo-keto reductase family 1 member C1 | 85.69% | 91.79% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 85.58% | 95.89% |
| CHEMBL5028 | O14672 | ADAM10 | 85.55% | 97.50% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 85.47% | 96.21% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 85.40% | 92.88% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 85.22% | 95.58% |
| CHEMBL205 | P00918 | Carbonic anhydrase II | 85.09% | 98.44% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 84.42% | 96.37% |
| CHEMBL245 | P20309 | Muscarinic acetylcholine receptor M3 | 84.40% | 97.53% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 84.24% | 80.71% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 84.12% | 89.33% |
| CHEMBL4805 | Q99572 | P2X purinoceptor 7 | 84.06% | 97.50% |
| CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 83.66% | 97.56% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 83.27% | 89.62% |
| CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 83.20% | 89.67% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 83.10% | 97.14% |
| CHEMBL3055 | P50613 | Cyclin-dependent kinase 7 | 82.78% | 81.88% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 82.78% | 89.34% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 82.28% | 94.00% |
| CHEMBL3837 | P07711 | Cathepsin L | 82.09% | 96.61% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 81.65% | 96.61% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 81.59% | 97.29% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 81.42% | 94.33% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 80.58% | 85.11% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 71459739 |
| LOTUS | LTS0123232 |
| wikiData | Q75065772 |